COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 982: Articles 9811-9820  | Next

Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques
Chandrashekar, A., Yu, J., McMahan, K., Jacob-Dolan, C., Liu, J., He, X., Hope, D., Anioke, T., Barrett, J., Chung, B., Hachmann, N., Lifton, M., Miller, J., Powers, O., Sciacca, M., Sellers, D., Siamatu, M., Surve, N., VanWyk, H., Wan, H., Wu, C., Pessaint, L., Valentin, D., Van Ry, A., Muench, J., Boursiquot, M., Cook, A., Velasco, J., Teow, E., Boon, A., Suthar, M., Jain, N., Martinot, A. J., Lewis, M. G., Andersen, H., Barouch, D. H.
10.1101/2022.02.06.479285 — Posted: 2022-02-07
A potent SARS-CoV-2 neutralizing antibody recognizing a conserved epitope with broad mutant variant and SARS-CoV activity.
Pelzek, A. J., Ebtehaj, S., Lulo, J., Zhang, L., Balduf, O., Dolan, L., Zhang, C., Wan, S., An, G., Kankam, A., Chan, E., Murphy, S. P.
10.1101/2022.02.06.479332 — Posted: 2022-02-07
An mRNA vaccine candidate for the SARS-CoV-2 Omicron variant
Zang, J., Zhang, C., Yin, Y., Xu, S., Qiao, W., LAVILLETTE, D., Wang, H., Huang, Z.
10.1101/2022.02.07.479348 — Posted: 2022-02-07
Mechanistic origin of different binding affinities of SARS-CoV and SARS-CoV-2 spike RBDs to human ACE2
Zhang, Z.-B., Xia, Y.-L., Shen, J.-X., Du, W.-W., Fu, Y.-X., Liu, S.-Q.
10.1101/2022.02.05.479221 — Posted: 2022-02-07
SARS-CoV-2 variant of concern type and biological sex affect efficacy of molnupiravir in dwarf hamster model of severe COVID-19
Lieber, C. M., Cox, R., Sourimant, J., Wolf, J. D., Juergens, K., Phung, Q., Saindane, M. T., Natchus, M. G., Painter, G. R., Sakamoto, K., Greninger, A. L., Plemper, R. K.
10.1101/2022.02.04.479171 — Posted: 2022-02-07
Detection of SARS-CoV-2 Omicron variant (B.1.1.529) infection of white-tailed deer
Vandegrift, K. J., Yon, M., Surendran-Nair, M., Gontu, A., Amirthalingam, S., Nissly, R. H., Levine, N., Stuber, T., DeNicola, A. J., Boulanger, J. R., Kotschwar, N., Aucoin, S. G., Simon, R., Toal, K., Olsen, R. J., Davis, J. J., Bold, D., Gaudreault, N. N., Richt, J. A., Musser, J. M., Hudson, P. J., Kapur, V., Kuchipudi, S. V.
10.1101/2022.02.04.479189 — Posted: 2022-02-07
Mutations of Omicron variant at the interface of the receptor domain motif and human angiotensin-converting enzyme-2
Adhikari, P., Jawad, B., Podgornik, R., Ching, W.-Y.
10.1101/2022.02.04.479136 — Posted: 2022-02-07
A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
Shrimp, J. H., Janiszewski, J., Chen, C. Z., Xu, M., Wilson, K. M., Kales, S. C., Sanderson, P. E., Shinn, P., Itkin, Z., Guo, H., Shen, M., Klumpp-Thomas, C., Michael, S. G., Zheng, W., Simeonov, A., Hall, M. D.
10.1101/2022.02.04.479134 — Posted: 2022-02-07
Comparative analysis of cell-cell communication at single-cell resolution
Wilk, A. J., Shalek, A. K., Holmes, S. P., Blish, C. A.
10.1101/2022.02.04.479209 — Posted: 2022-02-07
ARTIFICIAL INTELLIGENCE TOOLS FOR EFFECTIVE MONITORING OF POPULATION AT DISTANCE DURING COVID-19 PANDEMIC. RESULTS FROM AN ITALIAN PILOT FEASIBILITY STUDY (RICOVAI-19 STUDY).
Mazzanti, M., Salvi, A., Giacomini, S., Perazzini, E., Nitti, C., Contucci, S., D'Angelo, M., Ballanti, D., Ursino, D., Marcosignori, M., Romagnoli, R., Tavio, M., Giacometti, A., Tomassetti, S., Bonazzi, R., Maccioni, M., Zuccatosta, L.
10.1101/2022.02.04.22270087 — Posted: 2022-02-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).